GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.45 $5.86 Thursday, 18th Apr 2024 BCRX stock ended at $4.50. This is 1.75% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 4.90% from a day low at $4.49 to a day high of $4.71.
90 days $4.45 $6.35
52 weeks $4.45 $9.07

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
2023-08-08 $6.76 $7.08 $6.62 $7.02 2 651 578
2023-08-07 $7.60 $7.63 $6.68 $6.71 4 678 294
2023-08-04 $7.37 $7.87 $6.99 $7.60 5 222 267
2023-08-03 $7.18 $7.50 $6.91 $7.08 5 631 833
2023-08-02 $6.87 $7.11 $6.78 $6.95 5 164 701
2023-08-01 $7.57 $7.48 $6.94 $6.97 3 727 895
2023-07-31 $7.67 $7.67 $7.35 $7.39 2 217 590
2023-07-28 $7.65 $7.88 $7.57 $7.68 1 961 735
2023-07-27 $7.95 $7.95 $7.71 $7.75 1 522 478
2023-07-26 $7.64 $7.93 $7.59 $7.92 2 663 994
2023-07-25 $7.34 $7.74 $7.33 $7.64 1 745 141
2023-07-24 $7.48 $7.56 $7.31 $7.36 1 398 653
2023-07-21 $7.24 $7.54 $7.22 $7.47 1 817 498
2023-07-20 $7.36 $7.53 $7.15 $7.17 2 037 837
2023-07-19 $7.24 $7.47 $7.24 $7.36 2 134 856
2023-07-18 $7.15 $7.28 $7.10 $7.17 1 415 013
2023-07-17 $7.13 $7.40 $7.11 $7.19 2 853 601
2023-07-14 $7.35 $7.34 $7.01 $7.13 1 738 290
2023-07-13 $7.65 $7.74 $7.31 $7.35 2 739 371
2023-07-12 $7.28 $7.28 $7.16 $7.18 1 131 645
2023-07-11 $7.36 $7.40 $7.17 $7.19 1 714 763
2023-07-10 $6.96 $7.40 $6.94 $7.37 3 125 779
2023-07-07 $6.92 $7.12 $6.92 $6.98 1 349 225
2023-07-06 $6.97 $7.01 $6.82 $6.96 2 157 961
2023-07-05 $7.05 $7.08 $6.92 $7.04 2 027 023
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT